Multimodality Brain Imaging Markers in Progressive Supranuclear Palsy Subtypes and Parkinson's Disease
Movement Disorders Clinical Practice · 2025
DOI: 10.1002/mdc3.14346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Kanchana Soman Pillai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson and Movement Disorders Centre, Department of Neurology, Aster Medcity, Kochi, Kerala, India. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Parkinson Disease, Brain, Multimodal Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Aster Medcity Intramural research fund.
Abstract (Originalsprache)
Background
The new classification of progressive supranuclear palsy (PSP) subtypes necessitates identifying radiological biomarkers to support the clinical diagnosis.
Objective
The goal was to test if magnetic resonance imaging (MRI) morphometry, diffusion tensor imaging (DTI), susceptibility‐weighted imaging (SWI), or [18F]fluorodeoxyglucose ( 18F FDG)‐positron emission tomography (PET) differentiates PSP subtypes from each other or Parkinson's disease (PD).
Methods
Midbrain/pons (M/P) area ratio, middle/superior cerebellar peduncle (MCP/SCP) width ratio, magnetic resonance parkinsonism indices (MRPI and MRPI2) and midbrain antero‐posterior (AP) diameter were measured. Region of interest‐based DTI, SWI, and 18F FDG‐PET analyses were performed.
Results
Four PSP subtypes (n = 85) and 24 PD were studied. MRI morphometry and DTI could differentiate PSP‐Richardson syndrome (PSP‐RS) from PSP‐parkinsonism, PSP‐postural instability, and PD (area under curve >0.7). SWI did not differentiate among PSP subtypes or PD. 18F FDG‐PET distinguished PSP from PD.
Conclusions
MRI morphometry and DTI differentiated PSP‐RS from the other common PSP subtypes and PD and may be tested as a radiological marker of PSP‐RS in larger studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Parkinson and Movement Disorders Centre, Department of Neurology, Aster Medcity, Kochi, Kerala, India.
- Department of Radiology, Aster CMI Hospital, Bengaluru, Karnataka, India.
- Department of Nuclear Medicine, Aster Medcity, Kochi, Kerala, India.
- Department of Radiology, Aster Medcity, Kochi, Kerala, India.
ORCID-Profile: Kanchana Soman Pillai, Manas Chacko, Asha Kishore
Förderung
- Aster Medcity Intramural research fund
Zitieren
APA
Pillai, K. S., Rajeswari, P., Kamble, R. B., Gopalan Nair Santhamma, S., Chacko, M., Jayakrishnan, V., Ramachandran, R., Avarachan, A., & Kishore, A. (2025). Multimodality Brain Imaging Markers in Progressive Supranuclear Palsy Subtypes and Parkinson's Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14346
Vancouver
Pillai KS, Rajeswari P, Kamble RB, Gopalan Nair Santhamma S, Chacko M, Jayakrishnan V, et al. Multimodality Brain Imaging Markers in Progressive Supranuclear Palsy Subtypes and Parkinson's Disease. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.14346
BibTeX
@article{Pillai2025,
author = {Pillai, Kanchana Soman and Rajeswari, Parvathy and Kamble, Ravindra B and Gopalan Nair Santhamma, Shagos and Chacko, Manas and Jayakrishnan, Vijay and Ramachandran, Ranjini and Avarachan, Ayana and Kishore, Asha},
title = {Multimodality Brain Imaging Markers in Progressive Supranuclear Palsy Subtypes and Parkinson's Disease},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.14346}
}
EUVIMED